NEJM August 2026 Finerenone in Persons with Chronic Kidney Disease without Diabetes

This Week In Medicine · Aug 11, 2026 · 1m

This clinical study investigates whether the drug finerenone, previously proven effective for diabetic patients, can also protect the health of individuals with chronic kidney disease without diabetes. By tracking the rate of decline in kidney filtration over nearly three years, researchers discovered that those taking the medication experienced a significantly slower loss of renal functioncompared to those on a placebo. Beyond just preserving the kidneys, the treatment also demonstrated a measurable reduction in major cardiovascular and renal complications, such as heart failure or organ…